Pharmacological Interventions for Prevention of CVAs Course

By HomeCEU

  • Webcast
  • Contact Hours : 1 +
  • Free


Pharmacological Interventions for Prevention of CVAs Course is organized by HomeCEU.

Target Audience:
Physical Therapist, Physical Therapist Assistant, Occupational Therapist, Occupational Therapist Assistant, Speech Language Pathologist, Certified Athletic Trainer, Massage Therapist, Licensed Massage Therapist, Nurses, Nursing Home Administrator, Respiratory Therapist, Licensed Master Social Worker, Licensed Clinical Social Worker, Registered Dietician, Registered Dietician Nutritionist, Licensed Dietician

Contact Hours: 

1 contact hour in length (check your state’s approval status in the state specific course catalog for your profession).
This course is offered for 0.10 ASHA CEUs (Intermediate level, Professional area).

Course Description:
Rehabilitation providers will encounter many patients who are at risk for cerebrovascular accidents (CVAs). Being able to identify these risk factors is an essential part of thorough care. In addition, rehabilitation providers needs to be able to identify the medications that patients are taking to address these risk factors. Along with identifying the medications, comes the understanding of side effects, clinical implications and when to refer the patient back to the physician.

This course will review the risk factors for CVAs and will discuss in-depth the medications that are most commonly prescribed to treat these. This discussion will include side effects and clinical implications.

Course Goals:
This course is intended to instruct the professional on working with patients who are at risk for CVAs, should have knowledge of their medications and how they play a role in prevention. In addition, these healthcare professionals should be aware of side effects, clinical implications and have an awareness of when the medical team needs to be alerted. When this level of understanding occurs, rehabilitation professionals have the potential to further reduce the risk of CVAs in those that are high risk.

Professional Objectives:
• Identify 3 risk factors for CVAs
• Identify the most common side effect of hypertensive medications.
• Identify the two most common classes of drugs used to treat hyperlipidemia.
• List two classes of drugs commonly used to treat/manage atrial fibrillation.

Fee Details:
Mail: $35.00

Additional details will be posted as soon as they are available.


Registration Name Category Last Date Price
Early Fee Free

Credit Info

  • Contact Hours : 1
  • CEUs : 0.1


  • Neurology
  • Clinical Pharmacology

Speaker (s)

1 Speaker(s)

Contact Us


Toll free Number

1(800) 828-2059


Chat Assistant

Live Chat

Recommended Conferences

Infectious Disease
Specialties in Remote Settings
Webcast Jan 01, 2022 - Dec 31, 2023

Infectious Disease +6 More

AMA PRA Category 1 Creditâ„¢ 12

USD 360

Clinical Pharmacology
Global Clinical Trials Connect 2022
Live Webinar Sep 21 - 22, 2022

Clinical Pharmacology +2 More

GBP 357.40

Emirates Society of Rehabilitation & Sports Medicine (ESRSM) Annual Conference 2022 in Association with 2nd Regional Neurorehabilitation Conference (supported by WFNR) & 3rd MENASCI Annual Congress
Hybrid Event Sep 23 - 25, 2022

Neurology +2 More

AED 350

Medical Books